Regulatory mechanisms of dopamine biosynthesis at the tyrosine hydroxylase step.
D015107:4-Butyrolactone / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D003994:Bucladesine / Q000494:pharmacology; D003342:Corpus Striatum / Q000201:enzymology; D004298:Dopamine / Q000031:analogs & derivatives / Q000096:biosynthesis*; D004789:Enzyme Activation; D006220:Haloperidol / Q000494:pharmacology; D010766:Phosphorylation; D011954:Receptors, Dopamine / Q000502:physiology; D013569:Synapses / Q000201:enzymology; D013574:Synaptosomes / Q000201:enzymology; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors* / Q000378:metabolism
D011954:Receptors, Dopamine; D003994:Bucladesine; D014446:Tyrosine 3-Monooxygenase; D006220:Haloperidol; D001058:Apomorphine; D015107:4-Butyrolactone; D004298:Dopamine